Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022GlobeNewsWire • 04/29/22
Novo Nordisk's Ozempic drug gets FDA OK for 2 mg dose to treat Type-2 DiabetesMarket Watch • 03/29/22
Trading in Novo Nordisk shares by board members, executives and associated persons on 8 February 2022GlobeNewsWire • 02/11/22
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 4 February 2022GlobeNewsWire • 02/09/22
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 2-4 February 2022GlobeNewsWire • 02/04/22
Novo Nordisk A/S (NVO) CEO Lars Jorgensen on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/02/22
Novo Nordisk Posts Upbeat Q4 Earnings, Expects Obesity Drug Shortages May Soon Be ResolvedBenzinga • 02/02/22
Novo Nordisk's sales increased by 11% in Danish kroner and by 14% at constant exchange rates to DKK 140.8 billion in 2021GlobeNewsWire • 02/02/22